The effect of quetiapine on psychotic-like symptoms in borderline personality disordered patients: A randomised placebo-controlled trial

Trial Profile

The effect of quetiapine on psychotic-like symptoms in borderline personality disordered patients: A randomised placebo-controlled trial

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2009

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Borderline personality disorders
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 16 Jun 2009 Trial phase changed from III to II as reported by ClinicalTrials.gov.
    • 03 Sep 2008 Results presented at ECNP 2008.
    • 17 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top